Diligence memo · auto-generated · as of July 2, 2026
Invicta Medical, Inc.
Invicta Medical, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Invicta Medical, Inc. operates in Healthtech, based in SANTA CLARA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Invicta Medical, Inc. has raised $55M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2022-10-11.
Most recent recorded round closed around 2022-10-11.
Valuation (modeled)modeled
Provath models Invicta Medical, Inc. at approximately $296M (range $59M–$737M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.79× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 19 months.
Last raise 3.7 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 1.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 92% of Healthtech peers (2138 compared).
Modeled value ranks above 89% of those peers.
Closest niche peers: Casana Care, Inc., Mendel Health Inc., Bicycle Health Inc., Brave Health, Inc., Flume Health, Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.